Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

11.96
-0.3400-2.76%
Post-market: 12.120.1600+1.34%19:30 EDT
Volume:2.47M
Turnover:29.51M
Market Cap:1.94B
PE:542.69
High:12.38
Open:12.29
Low:11.83
Close:12.30
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:1.79
T/O Rate:3.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:8.04
PE(LYR):269.39

Loading ...

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
Sep 02

Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley

TIPRANKS
·
Sep 02

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live
·
Sep 01

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

TIPRANKS
·
Sep 01

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

TIPRANKS
·
Sep 01

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

TIPRANKS
·
Sep 01

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.
·
Sep 01

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

TIPRANKS
·
Aug 29

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

TIPRANKS
·
Aug 29

Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026

TIPRANKS
·
Aug 27

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

TIPRANKS
·
Aug 27

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Vertex Highlights Fy2025 Revenue of $748M in Investor Presentation on Intelligent Tax Compliance Platform

Reuters
·
Aug 27

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.
·
Aug 25

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.
·
Aug 24

Is Vertex Pharmaceuticals (VRTX) Cheap Following Its Raised 2026 Revenue Guidance?

Simply Wall St.
·
Aug 23

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

TIPRANKS
·
Aug 21

Vertex Minerals Wins 24-Hour Operating Approval at Reward Gold Mine

TIPRANKS
·
Aug 20